Latest Breaking News On - Interventional urology - Page 3 : comparemela.com

Coloplast A/S - Announcement No 02/2024 - Interim Financial Report, H1 2023/24

Coloplast A/S - Announcement No 02/2024 - Interim Financial Report, H1 2023/24
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United kingdomAleksandra dimovskaKristian villumsenAnders lonning skovgaardSensura mioKristine husted munkWomen healthMen healthOstomy careContinence careRespiratory careAdvanced wound careAdvanced wound dressingsInterventional urologyAtos medicalIntellectual property

Coloplast A/S (OTCMKTS:CLPBF) Short Interest Update

Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 846,800 shares, a growth of 12.3% from the March 31st total of 754,100 shares. Based on an average trading volume of 300 shares, the days-to-cover ratio is […]

United kingdomUnited statesGet free reportChronic careContinence careRespiratory careInterventional urologyAdvanced wound careColoplasta sOtcmkts clpbf

Short Interest in Coloplast A/S (OTCMKTS:CLPBF) Rises By 12 3%

Short Interest in Coloplast A/S (OTCMKTS:CLPBF) Rises By 12 3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGet free reportChronic careContinence careRespiratory careInterventional urologyAdvanced wound care

Short Interest in Coloplast A/S (OTCMKTS:CLPBF) Expands By 12 3%

Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 846,800 shares, an increase of 12.3% from the March 31st total of 754,100 shares. Based on an average trading volume of 300 shares, the short-interest ratio is […]

United statesUnited kingdomGet free reportChronic careContinence careRespiratory careInterventional urologyAdvanced wound careColoplasta sOtcmkts clpbf

NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme

/PRNewswire/ Laborie Medical Technologies Corp. (Laborie), a leading diagnostic and therapeutic medical technology company, welcomed the inclusion of.

New hampshireUnited statesKyle knaufGynecology neonatal healthNational health serviceNational institute for healthPrnewswire laborie medical technologies corpSpecialized services device programmePatricia industriesMedical technologiesUrethral drug coated balloonOptilume urethralHigh cost tariff excluded devicesNational instituteCare excellenceVice president